The influence of dose reducing and extension of interval on 1st line folfox4 and folfox4 with bevacizumab
- At: 2010 FIP Congress in Lisbon (Portugal)
- Type: Poster
- By: OKAZAWA, Mikiko (NTT Medical Center Tokyo, Tokyo, Japan)
- Co-author(s): Orii, Takao (NTT Medical Center Tokyo, TOKYO, Japan)
Most of the patients undergoing FOLFOX4 need dose reducing and extension of interval because of adverse events. And some patients are afraid of decrease the effect of FOLFOX4 results from reducing dose reducing and extension of interval. On the other hand some patients require extension of interval for recovery from dull appetite or.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.